SEC Tracker
Get the app

Dianthus Therapeutics DNTH

Dianthus Therapeutics, Inc. entered into an underwriting agreement with Jefferies LLC

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Signs a material agreement (1.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Dianthus Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Stoke Therapeutics STOK public float $592M, Jun 30, 2025
  2. Trevi Therapeutics TRVI public float $588M, Jun 30, 2025
  3. Amphastar Pharmaceuticals AMPH public float $633M, Jun 30, 2025
  4. Anaptysbio ANAB public float $633M, Dec 31, 2025
  5. Evolus EOLS public float $560M, Jun 30, 2025